论文信息 - Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell Lung Cancer and Other Advanced Solid Tumors - 字舞流文

Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell Lung Cancer and Other Advanced Solid Tumors

D. Potvin | J. Christensen | Keunchil Park | G. Shapiro | H. Hurwitz | Sunil Sharma | D. Hong | B. Cho | L. Bazhenova | C. Kollmannsberger | R. Chao | K. Reckamp | V. Tassell | H. Der-Torossian | D. Faltaos